Pharmacological expansion of type 2 alveolar epithelial cells promotes regenerative lower airway repair
Type 2 alveolar epithelial cells (AEC2s) are stem cells in the adult lung that contribute to lower airway repair. Agents that promote the selective expansion of these cells might stimulate regeneration of the compromised alveolar epithelium, an etiology-defining event in several pulmonary diseases. From a high-content imaging screen of the drug repurposing library ReFRAME, we identified that dipeptidyl peptidase 4 (DPP4) inhibitors, widely used type 2 diabetes medications, selectively expand AEC2s and are broadly efficacious in several mouse models of lung damage. Mechanism of action studies revealed that the protease DPP4, in addition to processing incretin hormones, degrades IGF-1 and IL-6, essential regulators of AEC2 expansion whose levels are increased in the luminal compartment of the lung in response to drug treatment. To selectively target DPP4 in the lung with sufficient drug exposure, we developed NZ-97, a locally delivered, lung persistent DPP4 inhibitor that broadly promotes efficacy in mouse lung damage models with minimal peripheral exposure and good tolerability. This work reveals DPP4 as a central regulator of AEC2 expansion and affords a promising therapeutic approach to broadly stimulate regenerative repair in pulmonary disease.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:121 |
|---|---|
| Enthalten in: |
Proceedings of the National Academy of Sciences of the United States of America - 121(2024), 16 vom: 16. Apr., Seite e2400077121 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Shao, Sida [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Alveolar stem cells |
|---|
| Anmerkungen: |
Date Completed 12.04.2024 Date Revised 23.04.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1073/pnas.2400077121 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM370876776 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM370876776 | ||
| 003 | DE-627 | ||
| 005 | 20240423232340.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240411s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1073/pnas.2400077121 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1384.xml |
| 035 | |a (DE-627)NLM370876776 | ||
| 035 | |a (NLM)38598345 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Shao, Sida |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Pharmacological expansion of type 2 alveolar epithelial cells promotes regenerative lower airway repair |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 12.04.2024 | ||
| 500 | |a Date Revised 23.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Type 2 alveolar epithelial cells (AEC2s) are stem cells in the adult lung that contribute to lower airway repair. Agents that promote the selective expansion of these cells might stimulate regeneration of the compromised alveolar epithelium, an etiology-defining event in several pulmonary diseases. From a high-content imaging screen of the drug repurposing library ReFRAME, we identified that dipeptidyl peptidase 4 (DPP4) inhibitors, widely used type 2 diabetes medications, selectively expand AEC2s and are broadly efficacious in several mouse models of lung damage. Mechanism of action studies revealed that the protease DPP4, in addition to processing incretin hormones, degrades IGF-1 and IL-6, essential regulators of AEC2 expansion whose levels are increased in the luminal compartment of the lung in response to drug treatment. To selectively target DPP4 in the lung with sufficient drug exposure, we developed NZ-97, a locally delivered, lung persistent DPP4 inhibitor that broadly promotes efficacy in mouse lung damage models with minimal peripheral exposure and good tolerability. This work reveals DPP4 as a central regulator of AEC2 expansion and affords a promising therapeutic approach to broadly stimulate regenerative repair in pulmonary disease | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a DPP4 | |
| 650 | 4 | |a IPF | |
| 650 | 4 | |a alveolar stem cells | |
| 650 | 4 | |a lower airway repair | |
| 650 | 4 | |a regenerative medicine | |
| 650 | 7 | |a Dipeptidyl Peptidase 4 |2 NLM | |
| 650 | 7 | |a EC 3.4.14.5 |2 NLM | |
| 700 | 1 | |a Zhang, Nan |e verfasserin |4 aut | |
| 700 | 1 | |a Specht, Gregory P |e verfasserin |4 aut | |
| 700 | 1 | |a You, Shaochen |e verfasserin |4 aut | |
| 700 | 1 | |a Song, Lirui |e verfasserin |4 aut | |
| 700 | 1 | |a Fu, Qiangwei |e verfasserin |4 aut | |
| 700 | 1 | |a Huang, David |e verfasserin |4 aut | |
| 700 | 1 | |a You, Hengyao |e verfasserin |4 aut | |
| 700 | 1 | |a Shu, Jian |e verfasserin |4 aut | |
| 700 | 1 | |a Domissy, Alain |e verfasserin |4 aut | |
| 700 | 1 | |a Li, Shuangwei |e verfasserin |4 aut | |
| 700 | 1 | |a Nguyen-Tran, Van |e verfasserin |4 aut | |
| 700 | 1 | |a Joseph, Sean B |e verfasserin |4 aut | |
| 700 | 1 | |a Chatterjee, Arnab K |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, Jeffrey Jian |e verfasserin |4 aut | |
| 700 | 1 | |a Schultz, Peter G |e verfasserin |4 aut | |
| 700 | 1 | |a Bollong, Michael J |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Proceedings of the National Academy of Sciences of the United States of America |d 1915 |g 121(2024), 16 vom: 16. Apr., Seite e2400077121 |w (DE-627)NLM000008982 |x 1091-6490 |7 nnns |
| 773 | 1 | 8 | |g volume:121 |g year:2024 |g number:16 |g day:16 |g month:04 |g pages:e2400077121 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1073/pnas.2400077121 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 121 |j 2024 |e 16 |b 16 |c 04 |h e2400077121 | ||